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Abstract
Background: Preeclampsia involves endothelial dysfunction, platelet dysfunction/activation and
sympathetic over-activity similar to cardiovascular disorders (CVD). Depression, an independent
risk factor for progression of CVD, was found to be associated with an increased risk of
preeclampsia among Finnish women. We examined the relation between depression/depressive
symptoms and preeclampsia risk among Peruvian women.
Methods: The study included 339 preeclamptic cases and 337 normotensive controls. Depression
and depressive symptoms during pregnancy were assessed using the Patient Health Questionnaire
(PHQ-9). Odds ratios (OR) and 95% confidence intervals (CI) were estimated from logistic
regression models.
Results:  The prevalence of moderate depression was 11.5% among cases and 5.3% among
controls. The corresponding figures for moderate-severe depression were 3.5% for cases and 2.1%
for controls. Compared with non-depressed women, those with moderate depression had a 2.3-
fold increased risk of preeclampsia (95% CI: 1.2–4.4), while moderate-severe depression was
associated with a 3.2-fold (95% CI: 1.1–9.6) increased risk of preeclampsia. Associations of each of
the 9-items of the PHQ-9 depression screening module with preeclampsia risk were also observed.
Conclusion: Our findings are consistent with the only other published report on this topic.
Collectively, available data support recent calls for expanded efforts to study and address
depression among pregnant women.
Background
There is mounting evidence that depression is an inde-
pendent risk factor for the progression of cardiovascular
disease (CVD) [1]. Many factors can contribute to an
increased risk for CVD in depressed patients. The concept
of a bio-behavioral model to explain the relationship
between depression and CVD is gaining support in the lit-
erature [2,3]. This model includes characteristics ranging
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from an increased presence of classical risk factors for
CVD (such as smoking, inactivity, hypertension, and dia-
betes) to changes in the immune system and dysregula-
tion of the autonomic nervous system. Platelets from
depressed patients have also been found to have increased
5-hydroxytryptamine 2 (5-HT2) binding density, suggest-
ing that depressed patients may be at increased risk for
serotonin-mediated platelet activation and coronary
artery vasoconstriction [1].
Preeclampsia, a major cause of perinatal morbidity and
mortality, occurs in 5–7% of pregnancies and is diag-
nosed when both hypertension and proteinuria are
present [4]. Preeclampsia and CVD have overlapping risk
factors, such as hypertension and diabetes, and appear to
share similarities in pathophysiology, as both involve
endothelial damage, vasoconstriction, platelet activation,
and aggregation mediated by serotonin [5]. Because
depression is an independent risk factor for the progres-
sion of CVD [1], it may also be a potential risk factor for
preeclampsia. However, only one study has investigated
the link between depression and preeclampsia [6]. Kurki
and colleagues studied 623 pregnant nulliparous Finnish
women at low risk for preeclampsia. All women had a
healthy first trimester and were then evaluated using the
Beck Depression and Anxiety scale at a median of 12
weeks' gestation. The authors observed that depression
was associated with an increased risk of preeclampsia
[odds ratio (OR) 2.5; 95% confidence interval (CI): 1.2–
5.3] [6]. Taking into account the limited literature on this
topic, we evaluated the relationship between maternal
depression/depressive symptoms during pregnancy and
preeclampsia risk, using data from a large case-control
study of preeclampsia risk factors among Peruvian
women.
Methods
This case-control study was conducted at the Materno
Perinatal Institute of Lima and the Dos de Mayo Hospital
in Lima, Peru, from May 2004 through October 2005.
Both institutions are operated by the Peruvian govern-
ment and are primarily responsible for providing mater-
nity services to low-income women residing in Lima. This
study was approved by the ethical committees of both
hospitals. All participants provided written informed con-
sent.
Cases were selected from those women with a diagnosis of
preeclampsia. Potential preeclampsia cases were identi-
fied by daily monitoring of all new admissions to antepar-
tum wards, emergency room wards, and labor and
delivery wards of the study hospitals. Study subjects were
recruited during their hospital stay. Study personnel made
periodic visits to each ward in a fixed order for the pur-
poses of identifying potential cases and controls for the
present study. Preeclampsia was defined by sustained
pregnancy-induced hypertension with proteinuria [4].
Hypertension was defined as sustained blood pressures of
at least 140/90 mm Hg on or after 20 completed weeks'
gestation and on at least two occasions at least four hours
apart. Proteinuria was defined as a urine-protein concen-
tration ≥ 30 mg/dl (or 1+ on a urine dipstick) in at least
two random specimens collected at least four hours apart.
Approximately 95% of eligible cases approached and
asked to participate in the study elected to do so. There
were 6 eclampsia (preeclampsia further complicated by
maternal seizure) cases in the current study.
Controls were women with pregnancies uncomplicated
by pregnancy-induced hypertension or proteinuria. Each
day during the enrollment period, controls were num-
bered in the order in which they were admitted and iden-
tified. Subsequently, they were approached in the order in
which research personnel identified them. Of the 362
controls approached, 337 (93%) agreed to participate in
the study.
A standardized, structured questionnaire was used to col-
lect information regarding maternal sociodemographic,
medical, reproductive, and lifestyle characteristics during
in-person interviews. All interviews were conducted in the
hospital. We used the Patient Health Questionaire-9
(PHQ-9) to assess study subjects' experience of depression
or depressive symptoms during pregnancy. PHQ-9 is from
the Primary Care Evaluation of Mental Disorders Patient
Health Questionnaire (PRIME-MD PHQ) and it consists
of 9 items of depressive symptoms plus a question about
functional impairment. Each item was marked on a scale
from 0 to 3, and the circled numbers were added to obtain
scores ranging from 0 to 27. Maternal experience of
depression was determined by the response to the ques-
tion: "During the last nine months (during your preg-
nancy), how often have you been bothered by any of the
following problems?" Responses were coded, 0 = Not at
all; 1 = Several days; 2 = More than half the days; 3 =
Nearly every day. The problems were as follows: (i) Little
interest or pleasure in doing things; (ii) Feeling down,
depressed, or hopeless; (iii) Trouble falling or staying
asleep, or sleeping too much; (iv) Feeling tired or having
little energy; (v) Poor appetite or eating too much; (vi)
Feeling bad about yourself or feeling that you are a failure
or have let yourself or your family down; (vii) Trouble
concentrating on things such as reading the newspaper or
watching TV; (viii) Moving or speaking so slowly that
other people could have noticed. Or the opposite – being
so restless that you have been moving around a lot more
than usual; (ix) Thought that you would be better off
dead, or hurting yourself in some way. From these nine
items, we calculated the total score. We interpreted the
degree of depression according to total scores as follows:BMC Women's Health 2007, 7:15 http://www.biomedcentral.com/1472-6874/7/15
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Minimal = 0–4; Mild = 5–9; Moderate = 10–14; Moderate
to severe = 15–19; Severe ≥ 20 [7]. In a recent validation
study of the PHQ-9 questionnaire, the authors concluded
that the instrument is a reliable and valid measure of
depression severity and a useful clinical and research tool
[7]. We also explored the association between the fre-
quency of experiencing each depressive symptom and
preeclampsia risk.
Maternal and infant records were reviewed to collect
detailed information concerning antepartum, labor, and
delivery characteristics, as well as conditions of the new-
born. Maternal anthropometric measures (height, weight,
and mid-arm circumference) were taken during partici-
pants' hospital stays. Gestational age was based on the
date of the last menstrual period and was confirmed by an
ultrasound examination performed before 20 weeks. Pre-
pregnancy body mass index (BMI), a measure of overall
maternal adiposity, was calculated as weight in kilograms
divided by height in meters squared. Women were classi-
fied as lean (BMI < 19.8 kg/m2), normal (BMI = 19.8–26.0
kg/m2), overweight (BMI = 26.1–29.0 kg/m2) and obese
(BMI > 29.0 kg/m2), based on the Institute of Medicine's
criteria [8].
We examined the frequency distribution of maternal soci-
odemographic characteristics and reproductive histories
according to case and control status. Initial univariate
analyses were carried out in order to determine unad-
justed odds ratios (ORs) and 95% confidence intervals
(CIs). Effect modification was evaluated by stratified anal-
yses and by including appropriate interaction terms in
logistic regression models [9]. If there appeared to be no
effect modification, logistic regression procedures were
used to simultaneously control for confounding variables
while estimating ORs and 95% CIs. Confounders were
defined as those factors that altered unadjusted ORs by at
least 10%. Final logistic regression models included con-
founders, as well as those covariates of a priori interest
(i.e., maternal age and parity). All analyses were per-
formed using STATA 9.0 statistical software (Stata, College
Station, Texas, USA). All continuous variables are pre-
sented as mean ± standard deviation (SD). All reported p-
values are two-tailed, and all confidence intervals were
calculated at the 95% level.
Results
Sociodemographic and reproductive characteristics of
cases and controls are presented in Table 1. Compared
with controls, cases tended to be older, single, heavier,
and nulliparous. They were also more likely to be
employed during pregnancy. Preeclampsia cases were
more likely to deliver preterm term and to deliver by
cesarean section.
The prevalence of moderate depression (score 10–14) was
11.5% among preeclamptic women and 5.3% among
normotensive controls (Table 2). The corresponding fig-
ures for moderate to severe depression (score 15–19) were
3.5% for cases and 2.1% for controls. Compared with
minimally depressed women (score 0–4), those with
moderate depression during pregnancy had a 2.6-fold
increased risk of preeclampsia (OR = 2.6; 95% CI: 1.4–
4.6). The association was attenuated slightly after adjust-
ing for maternal age, parity, and pre-pregnancy body mass
index (OR = 2.3; 95% CI: 1.2–4.4). Moderate to severe
depression was associated with a 3.2-fold (95% CI: 1.1–
9.6) increased risk of preeclampsia after adjusting for con-
founders. An extremely small number of subjects (two
preeclampsia cases and no normotensive controls) with
severe depression prohibited further study of this spec-
trum of depression with preeclampsia risk.
Table 3 shows associations between the frequency of each
of the depressive symptoms and preeclampsia risk. Each
depressive symptom was associated with increased preec-
lampsia risk. However, we did not observe trends in risk
across increasing frequency of any of the seven symptoms.
For example, women who experienced little interest or
pleasure in performing activities during several days of
their pregnancies was at 2.5-fold increased risk compared
with women who did not report this symptom (OR = 2.5;
95% CI: 1.7–3.7). Women who experienced this symp-
tom for more than half the pregnancy were at roughly
similarly increased risk (OR = 2.2; 95% CI: 1.1–4.4).
Discussion
Our findings of associations between depression and
preeclampsia in Peruvian women are consistent with the
only other published report on this topic, based on a
study of Finnish women [6]. We report that the individual
depression symptoms appear to be generally similar in the
strength of their relationship to preeclampsia. We were
unable to observe a trend of increased preeclampsia risk
with frequency of depressive symptoms because we were
limited by the low number of responses in the category of
the highest frequency (nearly everyday).
Traditionally, pregnancy is considered a period of well-
being and happiness, and was once thought to protect
women from depression [10]. However, women of child-
bearing age frequently suffer from major depression
[11,12]. The prevalence of moderate to severe depression
in our self-report screen module was 15.6% in preeclamp-
sia cases and 7.4% in control subjects. These frequencies
are generally consistent with the meta-analysis report by
Gaynes et al [12], in which the authors reported that the
combined estimates of point prevalence ranged from
8.5% to 11.0% at different times during pregnancy for
major and minor depression. The authors summarizedBMC Women's Health 2007, 7:15 http://www.biomedcentral.com/1472-6874/7/15
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data from a large number of studies that used a wide vari-
ety of depression screening and diagnostic instruments
including the Beck Depression Inventory (BDI) and the
Center for Epidemiologic Studies Depression Scale (CES-
D). Findings across studies were reasonably similar
despite different depression assessment approaches and
characteristics of study populations.
Our finding of an increased risk of preeclampsia with
maternal depression is consistent with numerous reports
that focused on the occurrence of cardiovascular diseases
Table 1: Sociodemographic and Reproductive Characteristics of the Study Population, Lima, Peru, 2004–2005
Characteristics Preeclampsia Cases (N = 339) Control Subjects (N = 337) P-value
n% n %
Maternal age at delivery (years) 27.0 ± 7.1* 25.7 ± 5.8 0.01
Maternal age at delivery (years)
< 20 44 13.0 34 10.1 0.003
20–34 229 67.5 265 78.6
≥ 35 66 19.5 38 11.3
Maternal education ≤ 12 years 289 85.3 300 89.0 NS
Single married status 81 24.2 45 13.4 < 0.01
Employed during pregnancy 134 39.5 98 29.1 0.02
Nullipara 160 47.2 117 34.7 < 0.05
No prenatal vitamins 68 20.1 59 17.5 NS
Gestational age at delivery (weeks) 37.4 ± 3.1 * 39.0 ± 2.2 < 0.001
< 28 6 1.8 3 0.9 < 0.001
28–33 35 10.3 7 2.1
34–36 48 14.2 11 3.2
≥ 37 250 73.7 316 93.8
Infant birth weight (grams) 2852.9 ± 830.6 * 3248.2 ± 621.1 < 0.001
Pre-pregnancy body mass index (kg/m2) 24.8 ± 4.4 * 23.1 ± 3.3 < 0.001
Pre-pregnancy body mass index (kg/m2)
< 19.8 (lean) 32 9.4 29 8.6 < 0.001
19.8–26.0 (normal) 182 53.7 245 72.7
26.1–29.0 (overweight) 60 17.7 34 10.1
> 29.0 (obese) 53 15.6 16 4.7
Missing 12 3.5 13 3.9
Delivery mode
Vaginal delivery 108 31.9 318 94.4 < 0.001
Cesarean delivery 230 67.9 19 5.6
We employed a two-sample Student's t-test to compare the continuous variables between preeclampsia cases and controls; and Chi-square tests or 
Fisher's exact tests were used to compare the categorical variables between the two groups.
NS = not statistically significant.
* Mean ± SD (standard deviation)
Table 2: Odds Ratios (OR) and 95% Confidence Intervals (CI) for Preeclampsia According to Maternal History of Depression during 
Pregnancy, Lima, Peru, 2004–2005
Maternal History of 
Depression (total score)
Preeclampsia Cases (N = 339) Control Subjects (N = 337) Unadjusted OR (95% CI) Adjusted OR (95% CI)
n (%) n (%)
Minimal (< 4) 180 (53.1) 213 (63.2) 1.0 (referent) 1.0 (referent)
Mild (5–9) 106 (31.3) 98 (29.1) 1.3 (0.9–1.8) 1.2 (0.9–1.8)
Moderate (10–14) 39 (11.5) 18 (5.3) 2.6 (1.4–4.6) 2.3 (1.2–4.4)
Moderate-severe (15–19) 12 (3.5) 7 (2.1) 2.0 (0.8–5.3) 3.2 (1.1–9.6)
Severe (≥ 20) 2 (0.6) 0 (0.0) --- ---
Missing 0 (0.0) 1 (0.3)
p-value for trend 0.001 0.001
Adjusted by maternal age (continuous), nulliparity (yes vs. no), maternal overweight status (pre-pregnancy body mass index ≤ 26.0 vs. > 26.0 kg/m2).BMC Women's Health 2007, 7:15 http://www.biomedcentral.com/1472-6874/7/15
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Table 3: Odds Ratios (OR) and 95% Confidence Intervals (CI) for Preeclampsia According to Maternal History of Depressive 
Symptoms during Pregnancy as Measured by the PHQ-9 Item Questionnaire, Lima, Peru, 2004–2005
PHQ-9 Items Preeclampsia Cases (N = 339) Control Subjects (N = 337) Unadjusted OR (95% CI) Adjusted OR (95% CI)
Little interest or pleasure in doing things
Not at all 185 247 1.0 (referent) 1.0 (referent)
Several days 128 68 2.5 (1.8–3.6) 2.5 (1.7–3.7)
More than half the days 26 21 1.7 (0.9–3.0) 2.2 (1.1–4.4)
Nearly every day 0 1 --- ---
Feeling down, depressed, or hopeless
Not at all 92 141 1.0 (referent) 1.0 (referent)
Several days 101 40 3.9 (2.5–6.1) 3.7 (2.3–5.9)
More than half the days 142 153 1.4 (1.0–2.0) 1.3 (0.9–1.9)
Nearly every day 4 3 2.0 (0.5–9.3) ---
Trouble falling or staying asleep, or sleeping too much
Not at all 184 220 1.0 (referent) 1.0 (referent)
Several days 73 36 2.4 (1.6–3.8) 2.4 (1.5–3.8)
More than half the days 77 79 1.2 (0.8–1.7) 1.2 (0.8–1.8)
Nearly every day 5 2 3.0 (0.6–15.6) 3.3 (0.6–18.8)
Feeling tired or having little energy
Not at all 168 206 1.0 (referent) 1.0 (referent)
Several days 93 58 2.0 (1.3–2.9) 1.8 (1.2–2.7)
More than half the days 76 71 1.3 (0.9–1.9) 1.3 (0.9–2.0)
Nearly every day 2 2 1.2 (0.2–8.8) 1.2 (0.2–10.1)
Poor appetite or eating too much
Not at all 176 227 1.0 (referent) 1.0 (referent)
Several days 75 51 1.9 (1.3–2.9) 1.8 (1.2–2.8)
More than half the days 80 57 1.8 (1.2–2.7) 1.7 (1.1–2.6)
Nearly every day 8 2 5.2 (1.1–24.6) 4.6 (0.9–23.4)
Feeling bad about yourself – or that you are a failure or have let yourself or your family down
Not at all 262 300 1.0 (referent) 1.0 (referent)
Several days 58 27 2.5 (1.5–4.0) 2.3 (1.4–3.9)
More than half the days 17 10 2.0 (0.9–4.3 2.1 (0.9–5.2)
Nearly every day 2 0 --- ---
Trouble concentrating on activities such as reading the newspaper or watching TV
Not at all 274 302 1.0 (referent) 1.0 (referent)
Several days 37 18 2.3 (1.3–4.1) 2.4 (1.3–4.6)
More than half the days 26 16 1.8 (0.9–3.4) 1.8 (0.9–3.7)
Nearly every day 2 1 2.2 (0.2–24.4) 3.0 (0.2–37.0)
Moving or speaking so slowly that other people could have noticed.
Not at all 307 323 1.0 (referent) 1.0 (referent)
Several days 15 7 2.3 (0.9–5.6) 2.0 (0.8–5.4)
More than half the days 15 6 2.6 (1.0–6.9) 3.2 (1.1–9.1)
Nearly every day 2 0 --- ---
Missing 0 1
Thought that you would be better off dead or hurting yourself in some way
Not at all 260 276 1.0 (referent) 1.0 (referent)
Several days 36 37 1.0 (0.6–1.7) 0.9 (0.5–1.5)
More than half the days 41 24 1.8 (1.1–3.1) 1.8 (0.99–3.3)
Nearly every day 2 0 --- ---
Degree of difficulty of daily living if you had any of above symptoms
Not difficult at all 175 183 1.0 (referent) 1.00 (referent)
Somewhat difficult 108 49 2.3 (1.6–3.4) 2.2 (1.4–3.3)
Very difficult 18 10 1.9 (0.9–4.2) 2.3 (0.9–5.7)
Extremely difficult 0 0 --- ---
Unknown or N/A 38 95
Adjusted by maternal age (continuous), nulliparity (yes vs. no) and maternal pre-pregnancy overweight statusBMC Women's Health 2007, 7:15 http://www.biomedcentral.com/1472-6874/7/15
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in depressed non-pregnant women and men [13,14].
Clinically diagnosed major depression has been shown to
be associated with more than doubling in risk of CVD
(pooled OR: 2.54, 95% CI: 2.07–3.10) [13]. Additionally,
investigators have reported that depressed mood is associ-
ated with increased risks of myocardial infarction, and
coronary heart disease (odds ratios ranging from 1.43 to
1.63) [13,14].
Several potential limitations should be taken into consid-
eration when interpreting the results of this study. First,
our analyses are based on cross-sectionally collected data,
which may be subject to recall bias. There has been one
longitudinal study of Finnish women [6]; however, more
longitudinal studies are needed to re-examine the poten-
tial causal relation between maternal experience of
depression and preeclampsia risk in different popula-
tions. Second, we used a depression screening instrument
to categorize participants according to depression/depres-
sive symptoms. Participants did not have formal diagnos-
tic examinations. As a result, some misclassification is
possible. However, Wulsin et al. [15] reported that the
PHQ-9 proved easy to administer to a population of poor,
young Honduran women who had never participated in
research before and were similar to Peruvian women
included in our study. The PHQ-9 results also showed a
sensitivity of 77% and a specificity of 100% compared
with the Structured Clinical Interview for DSW-IV mood
disorder module. In addition, our assessment of maternal
depression and depressive symptoms was limited to the
duration of the pregnancy. We did not collect information
to allow for the accurate sub-classification of mild and
severe preeclampsia. This limitation also hindered our
capability to further assess the correlation between sever-
ity of depression and severity of preeclampsia. Last,
although we adjusted for multiple confounding factors, as
with all observational studies, we cannot exclude the pos-
sibility of some residual confounding.
Associations between depression and increased risk of
preeclampsia are biologically plausible. Depression has
been associated with hypothalamic-pituitary-adrenal
(HPA) axis hyperactivity [16]. Maternal depression is
thought to activate the mother's HPA axis and, in turn, is
regulated by peptides derived from the activated HPA axis.
Depression may cause an increase in the release of corti-
cotropin-releasing hormone (CRH) from the placenta via
the actions of catecholamines and cortisol [17-20]. Smith
and colleagues examined the relationships between mood
changes, obstetric experience, and alterations in plasma
cortisol, beta-endorphin, and CRH in 97 women [20].
Plasma levels of these hormones were obtained through-
out pregnancy, at delivery, and postpartum. Smith and
colleagues reported that the prevalence of mood distur-
bances found in the late antenatal period was higher than
the level found in the postnatal period; the prevalence cor-
related with hormone levels, which peaked in late preg-
nancy and fell postpartum [20]. These data suggest a role
for CRH and the HPA axis in the relationship between
antenatal mood states and obstetric events. Depression
may be mediated by an altered excretion of vasoactive
hormones and other neuroendocrine transmitters. This
may in turn cause vasoconstriction and uterine artery
resistance and, therefore, elevate blood pressure [6,19].
Recent evidence also indicates the involvement of pro-
inflammatory cytokines in the pathogenesis of major
depression. The stress hormones may facilitate inflamma-
tion through induction of interleukins (IL) such as IL-1,
IL-6, IL-8, IL-18, tumor necrosis factor-alpha, and C-reac-
tive protein production [21].
Conclusion
Our results, combined with those reported by others [6],
suggest that the risk of preeclampsia is increased in
women experiencing depression during pregnancy. Avail-
able research suggests that depression is one of the most
common complications of pregnancy, and that fairly
accurate and feasible screening measures are available
[22-24]. Longitudinal cohort studies, with prospective
clinical assessment of depression, and studies in ethni-
cally and racially diverse populations are warranted.
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